Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Lulu YeRonald Wihal OeiFangfang KongTingting XuChunying ShenXiaoshen WangXiayun HeLin KongChaosu HuHong-Mei Ying

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2018)

High pre-treatment NLR and PLR indicated poor survival in NPC patients treated with IMRT-based therapy. As easily accessible and economically feasible biomarkers, NLR and PLR can be applied into clinical practice, in combination with current TNM staging, to design a more personalized treatment in these patients.

Keyphrases

clinical practice
end stage renal disease
ejection fraction
early stage
newly diagnosed
chronic kidney disease
radiation therapy
squamous cell carcinoma
stem cells
lymph node
combination therapy
patient reported outcomes
pet ct
locally advanced
free survival